Combination Oral Health Care Products Lack Sufficient Safety Data – J&J
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson argues against including combination oral health care products in the OTC antingingivitis/antiplaque monograph in Nov. 25 comments to FDA